Impaired Satiety Effect of GLP-1 Agonist in Obesity Is Associated With GLP-1 Resistance in Intestinal Afferent Nerves

被引:0
|
作者
Al-Helaili, Alaa
Wang, Beini
Beyak, Michael
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Tu1784
引用
收藏
页码:S842 / S842
页数:1
相关论文
共 50 条
  • [21] Effect of the GLP-1 Agonist Lixisenatide on the Pharmacokinetics of Warfarin
    Liu, Yan-Hong
    Ruus, Peter
    Steinstraesser, Axel
    Teichert, Lenore
    DIABETES, 2010, 59 : A558 - A558
  • [22] A Novel Antihypertensive Effect of Exenatide, a GLP-1 Agonist
    Dandona, Paresh
    Chaudhuri, Ajay
    Dhindsa, Sandip
    AMERICAN JOURNAL OF HYPERTENSION, 2010, 23 (03) : 228 - 228
  • [23] Brain GLP-1 and the regulation of food intake: GLP-1 action in the brain and its implications for GLP-1 receptor agonists in obesity treatment
    Trapp, Stefan
    Brierley, Daniel, I
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (04) : 557 - 570
  • [24] GLP-1 ANALOGS FOR THE TREATMENT OF OBESITY
    Sever, M. Jensterle
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A6 - A6
  • [25] GLP-1 and Amylin in the Treatment of Obesity
    T. Jorsal
    J. Rungby
    F. K. Knop
    T. Vilsbøll
    Current Diabetes Reports, 2016, 16
  • [26] GLP-1 and Amylin in the Treatment of Obesity
    Jorsal, T.
    Rungby, J.
    Knop, F. K.
    Vilsboll, T.
    CURRENT DIABETES REPORTS, 2016, 16 (01) : 1 - 7
  • [27] The Role of GIP in the Regulation of GLP-1 Satiety and Nausea
    Hayes, Matthew R.
    Borner, Tito
    De Jonghe, Bart C.
    DIABETES, 2021, 70 (09) : 1956 - 1961
  • [28] GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: Novel therapeutic agents for metabolic dysfunction-associated steatohepatitis
    Singh, Anmol
    Sohal, Aalam
    Batta, Akash
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (48)
  • [29] GLP-1 as a satiety factor in children with eating disorders
    Tomasik, PJ
    Sztefko, K
    Malek, A
    HORMONE AND METABOLIC RESEARCH, 2002, 34 (02) : 77 - 80
  • [30] Albiglutide: a unique GLP-1 receptor agonist
    Rendell, Marc S.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (12) : 1557 - 1569